lobbying_activities: 1126374

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1126374	f281434a-1bfe-4213-8ec3-aa932f2838d8	Q2	SHIRE PHARMACEUTICALS LLC	323477	SHIRE PHARMACEUTICALS LLC	2011	second_quarter	PHA	S. 296, Preserving Access to Life Saving Medicines Act; Life Sciences Investment Act; orphan drugs; end stage renal disease (ESRD) bundling of non-injectable oral equivalents; ESRD Quality Incentive program; Prescription Drug User Fee program; reimbursements; drug shortages; DEA quotas	SENATE		90000	0	0	2011-07-19T20:02:59.487000-04:00